Treatment patterns and economic outcomes in patients with juvenile idiopathic arthritis
Alexander Marshall,1 Kiran Gupta,1 Michael Pazirandeh,1 Machaon Bonafede,2 Donna McMorrow21Health Economics and Outcomes Research, Bristol-Myers Squibb, Lawrenceville, NJ, USA; 2IBM Watson Health, IBM, Cambridge, MA, USAPurpose: To describe health care resource utilization (HCRU) and costs among pat...
Saved in:
Main Authors: | Marshall A (Author), Gupta K (Author), Pazirandeh M (Author), Bonafede M (Author), McMorrow D (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2019-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Treatment effectiveness and treatment patterns among rheumatoid arthritis patients after switching from a tumor necrosis factor inhibitor to another medication
by: Bonafede MMK, et al.
Published: (2016) -
Early untreated juvenile idiopathic arthritis: predictors of outcome
by: Pascoli L, et al.
Published: (2008) -
ADALIMUMAB IN TREATMENT OF SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS
by: R. V. Denisova, et al.
Published: (2013) -
Current Treatments for Juvenile Idiopathic Arthritis
by: Alberto eMartini, et al.
Published: (2011) -
Economic impact of Juvenile Idiopathic Arthritis: a systematic review
by: Fernando García-Rodríguez, et al.
Published: (2021)